Annovis Bio, Inc. (ANVS)
NYSE: ANVS · Real-Time Price · USD
2.430
+0.050 (2.10%)
At close: Feb 18, 2026, 4:00 PM EST
2.470
+0.040 (1.65%)
After-hours: Feb 18, 2026, 4:22 PM EST
Annovis Bio Market Cap
Annovis Bio has a market cap or net worth of $64.4 million as of February 18, 2026. Its market cap has decreased by -4.15% in one year.
Market Cap
64.40M
Enterprise Value
51.24M
1-Year Change
-4.15%
Ranking
Category
Stock Price
$2.43
Market Cap Chart
Since January 29, 2020, Annovis Bio's market cap has increased from $62.51M to $64.40M, an increase of 3.03%. That is a compound annual growth rate of 0.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 17, 2026 | 63.08M | -31.21% |
| Dec 31, 2025 | 91.70M | 32.13% |
| Dec 31, 2024 | 69.40M | -63.84% |
| Dec 29, 2023 | 191.90M | 75.03% |
| Dec 30, 2022 | 109.64M | -23.01% |
| Dec 31, 2021 | 142.41M | 174.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NovaBay Pharmaceuticals | 68.45M |
| Pliant Therapeutics | 68.21M |
| Pelthos Therapeutics | 66.58M |
| ETHZilla | 66.16M |
| Alterity Therapeutics | 65.38M |
| MindWalk Holdings | 64.90M |
| Fractyl Health | 64.17M |
| ImmuCell | 59.70M |